Companion Diagnostics (CDX) in Precision Medicine

Kim, Il-Jin

  • 出版商: Pan Stanford Publish
  • 出版日期: 2019-03-04
  • 售價: $5,850
  • 貴賓價: 9.5$5,558
  • 語言: 英文
  • 頁數: 256
  • 裝訂: Hardcover - also called cloth, retail trade, or trade
  • ISBN: 9814800236
  • ISBN-13: 9789814800235




There is a new trend in anti-cancer therapeutics development: a targeted therapy and precision medicine that targets a subgroup of patients with specific biomarkers. An in vitro diagnostic (IVD) assay is required to identify a subgroup of cancer patients who would benefit from the targeted therapy, or not likely benefit, or have a high risk of side effects from the specific drug treatment. This IVD or medical device is called a companion diagnostic (CDx) assay. It is key to have a robust CDx assay or device for the success of targeted therapy and precision medicine.

This book covers the technical, historical, clinical, and regulatory aspects of CDx in precision medicine. Clearly, more and more newly developed oncology drugs will require accompanying CDx assays, and this book, with chapters contributed by renowned oncologists, provides a comprehensive foundation for the knowledge and application of CDx for precision medicine.


Il-Jin Kim (DVM, PhD, PMP, BCMAS, CCRP) was director of Applied Genomics in the UCSF Thoracic Oncology Program and is now medical director at Guardant Health, USA.